# Johnson & Johnson (JNJ) — Q1-2012 Earnings Results

**Report date:** 2012-04-17 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2012

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.41 | N/A | +3.98% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting operational efficiency as a key focus. However, they did not provide specific guidance for the future.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on maintaining strong operational efficiency.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report shows that Johnson & Johnson was able to exceed EPS expectations, which is a positive sign for the company's profitability. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, indicating limited immediate market response to the results.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2012_